TY - JOUR
T1 - Association of Variation at the ABO Locus With Circulating Levels of Soluble Intercellular Adhesion Molecule-1, Soluble P-selectin, and Soluble E-selectin A Meta-Analysis
AU - Kiechl, S
AU - Pare, G
AU - Barbalic, M
AU - Qi, L
AU - Dupuis, J
AU - Dehghan, Abbas
AU - Bis, JC
AU - Laxton, RC
AU - Xiao, QZ
AU - Bonora, E
AU - Willeit, J
AU - Xu, QB
AU - Witteman, JCM
AU - Chasman, D
AU - Tracy, RP
AU - Ballantyne, CM
AU - Ridker, PM
AU - Benjamin, EJ
AU - Ye, S
PY - 2011
Y1 - 2011
N2 - Background-Circulating levels of soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin have been associated with variation at the ABO locus. To evaluate these associations and the effect sizes, we performed a meta-analysis with new and previous reported data for polymorphism rs579459. Methods and Results-Compared with major allele homozygotes, heterozygotes and minor allele homozygotes had 4.6% (95% CI, 3.4%-5.8%, P=7.3X10(-14)) and 7.2% (95% CI, 4.7%-9.7%, P=1.5X10(-8)), respectively, lower soluble intercellular adhesion molecule-1 levels (n=33 671). An allele dose-dependent association also was observed for soluble P-selectin (n=4921) with heterozygotes and minor allele homozygotes having 11.5% (95% CI, 7.2%-15.8%, P=1.7X10(-7)) and 18.6% (95% CI, 9.1%-28.1%, P=1.2X10(-4)), respectively, lower levels than in major allele homozygotes. A larger effect size, again consistent with an additive genetic model, was seen for soluble E-selectin (n=2860) whose level was 25.6% (95% CI, 19.0%-32.2%, P=2.1X10(-14)) lower in heterozygotes and 43.3% (95% CI, 36.9%-49.3%, P=4.3X10(-42)) lower in minor allele homozygotes than in major allele homozygotes. Conclusions-The data support the association of variation at the ABO locus with soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin levels. (Circ Cardiovasc Genet. 2011;4:681-686.)
AB - Background-Circulating levels of soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin have been associated with variation at the ABO locus. To evaluate these associations and the effect sizes, we performed a meta-analysis with new and previous reported data for polymorphism rs579459. Methods and Results-Compared with major allele homozygotes, heterozygotes and minor allele homozygotes had 4.6% (95% CI, 3.4%-5.8%, P=7.3X10(-14)) and 7.2% (95% CI, 4.7%-9.7%, P=1.5X10(-8)), respectively, lower soluble intercellular adhesion molecule-1 levels (n=33 671). An allele dose-dependent association also was observed for soluble P-selectin (n=4921) with heterozygotes and minor allele homozygotes having 11.5% (95% CI, 7.2%-15.8%, P=1.7X10(-7)) and 18.6% (95% CI, 9.1%-28.1%, P=1.2X10(-4)), respectively, lower levels than in major allele homozygotes. A larger effect size, again consistent with an additive genetic model, was seen for soluble E-selectin (n=2860) whose level was 25.6% (95% CI, 19.0%-32.2%, P=2.1X10(-14)) lower in heterozygotes and 43.3% (95% CI, 36.9%-49.3%, P=4.3X10(-42)) lower in minor allele homozygotes than in major allele homozygotes. Conclusions-The data support the association of variation at the ABO locus with soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin levels. (Circ Cardiovasc Genet. 2011;4:681-686.)
U2 - 10.1161/CIRCGENETICS.111.960682
DO - 10.1161/CIRCGENETICS.111.960682
M3 - Article
SN - 1942-325X
VL - 4
SP - 681-U436
JO - Circulation-cardiovascular genetics
JF - Circulation-cardiovascular genetics
IS - 6
ER -